Moleculin Biotech Inc (MBRX)

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	3.98%7.56	7.87	7.53	5.91	5.72
Research and Development	1.34%5.45	5.38	5.12	3.74	3.60
Operating Income/Loss	3.98%-7.56	-7.87	-7.53	-5.91	-5.72
Income Tax Expense/Benefit	-	-	-	-	-
	40.56%-7.64	-12.85	15.55	-25.40	-7.64
Attributable To Parent	40.56%-7.64	-12.85	15.55	-25.40	-7.64
Available To Common Stockholders, Basic	45.49%-7.96	-14.61	-	-25.40	-17.81
Basic Average Shares	37.73%5.68	4.12	-	37.30	15.53
Basic Earnings Per Share	60.45%-1.40	-3.54	-	-0.68	-0.49